TSXV - Free Realtime Quote • CAD
Hemostemix Inc. (HEM.V)
As of 9:30 AM EDT. Market Open.
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
---|---|---|---|
Lacey (Peter Alan) Director of Issuer | Compensation for services | Mar 3, 2022 | -- |
Smeenk, Thomas Director of Issuer | Acquisition or disposition in the public market | Oct 25, 2022 | 1,219,125 |
Related Tickers
KNE.V Kane Biotech Inc.
0.1300
0.00%
IOT.V Innovotech Inc.
0.1300
0.00%
COV.V Covalon Technologies Ltd.
1.2000
0.00%
HAVN.CN HAVN Life Sciences Inc.
0.0300
0.00%
DOSE.CN Rapid Dose Therapeutics Corp.
0.2000
0.00%
VXLLF Vaxil Bio Ltd.
0.0053
0.00%
ARCH.V Arch Biopartners Inc.
2.3700
-0.42%
CZO.V Ceapro Inc.
0.2500
0.00%
NGEN.V NervGen Pharma Corp.
2.0200
+1.00%
VXL.V Vaxil Bio Ltd.
0.0150
0.00%